3230 Results

People

  1. Schoder
    Schoder
  2. Larson
    Larson
  3. Pandit-Taskar
    Pandit-Taskar
  4. Humm
    Humm
  5. Vargas Alvarez
    Vargas Alvarez
  6. Bodei
    Bodei
  7. Finn
    Finn
  8. Weber
    Weber
  9. Zanzonico
    Zanzonico
  10. Strauss
    Strauss

Groups

  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)
  7. Sloan Kettering Institute Postdocs (864)
  8. Body Imaging Service (649)
  9. Solid Tumor Oncology Division (647)
  10. Medical Physics (628)
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—A narrative review
    Review

    Krebs, S.; Barasch, J. G.; Young, R. J.; Grommes, C.; Schöder, H.
    Annals of Lymphoma (2021)

    Fulltext@MSK | Save
  • The role of myocardial perfusion imaging in cardiac clearance of cancer patients
    Book Section

    Fox, J. J.; Weinstein, H.
    In Steingart, R. M.; Liu, J. E. (Eds.) Atlas of Imaging in Cardio-Oncology: Case-Based Study Guide (2021)

    Fulltext@MSK | Save
  • Toxicity testing of indocyanine green and fluorodeoxyglucose conjugated iron oxide nanoparticles with and without exposure to a magnetic field
    Journal Article

    Unak, P.; Hepton, R.; Harper, M.; Yasakci, V.; Pearce, G.; Russell, S.; Aras, O.; Akin, O.; Wong, J.
    Asian Journal of Nanoscience and Materials (2021)

    Fulltext@MSK | Save
  • Effects of fluorodeoxyglucose magnetic nanoparticles on NCI-H727 and SH-SY5Y cancer cells
    Journal Article

    Unak, P.; Budiyo, R. C.; Horsnzky, A.; Yasakci, V.; Pearce, G.; Russell, S.; Aras, O.; Akin, O.; Wong, J.
    Asian Journal of Nanoscience and Materials (2021)

    Fulltext@MSK | Save
  • Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade
    Meeting Abstract

    Wills, B.; Michaud, L.; Schöder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Metabolic tumor volume and total lesion glycolysis can predict response to very low dose radiotherapy (4 Gy) in indolent B-cell lymphomas
    Meeting Abstract

    Wijetunga, N. A.; Imber, B. S.; Lee, J.; Hajj, C.; Mayerhoefer, M. E.; Schoder, H.; Yahalom, J.
    Blood (2021)

    Fulltext@MSK | Save
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Iomab with adoptive cellular therapy (Iomab-ACT): A pilot study of 131-I apamistamab followed by CD19-targeted car T-cell therapy for patients with relapsed or refractory B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma
    Meeting Abstract

    Geyer, M. B.; Cadzin, B.; Halton, E.; Kane, P.; Senechal, B.; Geoghegan, E. M.; Reddy, V.; Berger, M. S.; Ludwig, D.; Pandit-Taskar, N.; more...
    Blood (2021)

    Fulltext@MSK | Save